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Infantile Spasms during Acute Metabolic Decompensation in 
an Infant with Isovaleric Acidemia
Dear Editor,
Isovaleric acidemia (IVA) is a rare branched-chain organic acidemia caused by deficiency 
of isovaleryl-CoA dehydrogenase (IVD). Acute and chronic intermittent forms of IVA have 
been described. The acute form typically present during the neonatal period with acute en-
cephalopathy, vomiting, dehydration, and severe metabolic acidosis. The chronic intemittent 
form is characterized by periodic vomiting, lethargy, coma, ketoacidosis, and a ‘sweaty feet’ 
odor. Epileptic seizures have rarely been reported during the metabolic decompensation 
period.1 
Infantile spasms (IS) occur occasionally in patients with inborn errors of metabolism, in-
cluding organic acidurias.2 Here we report the occurrence of IS in a male infant diagnosed 
with IVA during an episode of metabolic decompensation, whose spasms were controlled 
with adrenocorticotropic hormone (ACTH) treatment. 
A 5-month-old boy was referred to our emergency room with symptoms of lethargy, vom-
iting, and flexor spasms marked by a series of sudden flexions of the head, trunk, arms, and 
legs over a 24-hour period. There was first-degree consanguinity between the parents, and 
the pregnancy was unremarkable except for intrauterine growth retardation. There was no 
history of psychomotor retardation or acute encephalopathy attacks. A laboratory investiga-
tion revealed metabolic acidosis with a high anion gap (pH: 7.31), lactic acidosis (7.8 mmol/L), 
and hyperammonemia (182 mol/L). The patient had mild renal failure (54 mg/dL blood urea 
nitrogen, 0.9 mg/dL serum creatinine, 7.2 mg/dL uric acid, and estimated glomerular filtra-
tion rate: 52.6 mL/min/1.73 m2). EEG revealed hypsarrhythmia, and so he was diagnosed with 
IS (Fig. 1). The findings of magnetic resonance imaging of the patient’s brain at diagnosis 
were normal. His acidosis and renal failure were treated with approciate fluid and bicarbon-
ate treatment, and vigabatrine (100 mg/kg/day) was initiated for spasms. Despite an im-
provement of metabolic acidosis and renal failure on the 6th day of hospitalization, the spasms 
were not controlled. Therefore, high dose synthetic ACTH (150 IU/m2/day) was adminis-
tered intramuscularly twice a week while he received vigabatrine. His spasms improved on 
day 5 of treatment, and the hypsarrhythmia resolved by day 30. IVA was diagnosed on the 
8th day of hospitalization, based on urine organic acid analysis showing an elevated con-
centration of isovalerylglycine and tandem mass spectrometry of acylcarnitines in dried blood 
spots showing elevated C5-carnitine (isovalerylcarnitine). Enzyme analysis of cultured fibro-
blasts showed decreased IVD levels. A protein-restricted diet, L-carnitine (100 mg/kg i.v. per 
day), and hydroxycobalamin were initiated for IVA. The side effects of ACTH therapy were 
noted, including irritability and weight gain. After 1 month, ACTH was ended and the patient 
remained seizure-free at 18 months after the treatment.
IVA is an uncommon branched-chain organic acidemia characterized by acute episodes 
of metabolic acidosis with a high anion gap, which may lead to coma and death. Develop-
mental delay is the most common neurologic finding of IVA. Epileptic seizures have rarely 
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been reported during the metabolic decompensation period 
or follow-ups. Ozgul et al.1 reported epileptic seizures in only 
3 out of 26 patients with IVA.
IS are uncommonly reported in inborn metabolic disor-
ders, but their prevalence is probably underestimated. More 
than 25 types of inborn errors of metabolism have been con-
sidered etiologic or predisposing factors for IS.3 Many studies 
have shown an association between branched-chain meta-
bolic disorders and IS, including vitamin B12 deficiency, meth-
ylmalonic aciduria and propionic acidemia.3,4 To the best of 
our knowledge, our case is the first to show an association be-
tween IVA and IS.
IS is treated by administereting ACTH, vitamin B6, vigaba-
trine, or other antiepileptic drugs. Steroids and ACTH can 
affect protein catabolism so as to lead to catastrophic metabol-
ic decompensation when an inborn errors of metabolizm is 
present. Rutledge et al.5 reported an IS patient controlled with 
ACTH who subsequently developed severe lactic acidosis, 
which led to a diagnosis of pyruvate carboxylase deficiency. 
On contrast, Campeau et al.4 described an infant with meth-
ylmalonic aciduria whose spasms were fully controlled by hy-
drocortisone therapy and without severe side effects. In the 
present case, we initiated ACTH after correcting metabolic ac-
idosis, and we did not observe any metabolic decompensa-
tion episode during follow-up. 
This present case illustrates that organic acidemias includ-
ing IVA should be kept in mind in the differential diagnosis of 
IS. Also, shortly after correcting metabolic decompensation, 
ACTH can be used safely and effectively to control IS in pa-
tients with IVA.
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Fig. 1. Interictal sleep EEG. Hypsarrhythmia with some periodicity.
